Kyungdong Pharm
KOSDAQ:011040
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kyungdong Pharm
KOSDAQ:011040
|
KR |
|
A
|
ASML Holding NV
F:ASME
|
NL |
|
Main Street Capital Corp
NYSE:MAIN
|
US |
|
Old Market Capital Corp
NASDAQ:OMCC
|
US |
|
A
|
Allstate Corp
XMUN:ALS
|
US |
|
Vera Bradley Inc
F:ELI
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Kyungdong Pharm's stock price target?
Not Available
Kyungdong Pharm does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Kyungdong Pharm?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 7 years is -1%.
What is the Gross Profit forecast for Kyungdong Pharm?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 7 years is -2%.
What is the Operating Income forecast for Kyungdong Pharm?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Operating Income has been -9%. The projected CAGR for the next 7 years is 22%.
What is the Pre-Tax Income forecast for Kyungdong Pharm?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -7%. The projected CAGR for the next 7 years is 18%.
What is the Net Income forecast for Kyungdong Pharm?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 7 years is 12%.
